Inogen (INGN) Stock Chart & Stock Price History → Why Big Pharma is Investing Billions in This Biotech (From Behind the Markets) (Ad) Free INGN Stock Alerts $6.78 +0.30 (+4.63%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inogen Stock Price Performance5 Day Performance+1.19%1 Month Performance-14.88%3 Month Performance+18.95%6 Month Performance+61.05%Year-To-Date Performance+23.50%1 Year Performance-48.20% Receive INGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy INGN Stock Chart for Saturday, April, 27, 2024 INGN Chart by TradingView Inogen Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$6.48$6.78+4.63%$6.78$6.47174,045 shs$159.67 million04/25/2024$7.05$6.48-8.09%$6.99$6.42197,484 shs$152.60 million04/24/2024$6.90$7.05+2.17%$7.07$6.72231,038 shs$166.01 million04/23/2024$6.70$6.90+2.99%$7.06$6.64184,495 shs$162.50 million04/22/2024$6.75$6.70-0.74%$6.84$6.62173,383 shs$157.79 million04/19/2024$7.09$6.75-4.80%$7.28$6.68260,838 shs$157.48 million Get the Latest News and Ratings for INGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$6.95$7.09+2.01%$7.19$6.77346,206 shs$165.41 million04/17/2024$6.93$6.95+0.29%$7.04$6.75464,067 shs$162.14 million04/16/2024$7.16$6.93-3.21%$7.22$6.83211,820 shs$161.68 million04/15/2024$7.36$7.16-2.72%$7.40$7.06309,033 shs$167.04 million04/12/2024$7.28$7.36+1.10%$7.38$6.95250,723 shs$171.71 million04/11/2024$7.40$7.28-1.62%$7.68$7.15228,981 shs$169.84 million04/10/2024$7.72$7.40-4.15%$7.71$7.15691,223 shs$172.64 million04/09/2024$6.43$7.72+20.06%$7.95$6.46820,152 shs$180.11 million04/08/2024$6.30$6.43+2.06%$6.57$6.15332,429 shs$150.01 million04/05/2024$6.65$6.30-5.26%$6.78$6.29327,628 shs$146.96 million04/04/2024$6.94$6.65-4.18%$7.24$6.56195,721 shs$155.14 million04/03/2024$7.09$6.94-2.12%$7.21$6.91172,158 shs$161.91 million04/02/2024$7.54$7.09-5.97%$7.38$6.88286,344 shs$165.41 million04/01/2024$8.07$7.54-6.57%$8.07$7.52235,614 shs$175.91 million03/29/2024$8.07$8.07$8.19$7.90315,844 shs$188.27 million03/28/2024$7.97$8.07+1.32%$8.19$7.90315,844 shs$188.27 million03/27/2024$7.74$7.97+2.91%$8.03$7.73242,307 shs$185.82 million03/26/2024$7.52$7.74+2.93%$7.83$7.55227,522 shs$180.57 million03/25/2024$7.07$7.52+6.36%$7.63$7.12328,971 shs$175.42 million03/22/2024$7.12$7.07-0.70%$7.14$6.84245,301 shs$164.94 million03/21/2024$6.89$7.12+3.34%$7.21$6.78221,229 shs$166.11 million03/20/2024$6.85$6.89+0.58%$7.00$6.64150,139 shs$160.72 million03/19/2024$6.84$6.85+0.15%$6.98$6.76198,700 shs$159.81 million03/18/2024$6.90$6.84-0.87%$7.22$6.67361,675 shs$159.58 million03/15/2024$6.75$6.90+2.22%$6.98$6.65296,398 shs$160.96 million03/14/2024$7.14$6.75-5.46%$7.15$6.64263,390 shs$157.48 million03/13/2024$6.98$7.14+2.29%$7.22$6.96241,017 shs$166.58 million03/12/2024$7.19$6.98-2.92%$7.20$6.77422,543 shs$162.84 million03/11/2024$7.59$7.19-5.27%$7.67$7.18216,940 shs$167.72 million03/08/2024$7.54$7.59+0.66%$8.02$7.52613,169 shs$177.08 million03/07/2024$7.03$7.54+7.25%$7.59$7.08410,172 shs$175.91 million03/06/2024$6.75$7.03+4.15%$7.15$6.73441,368 shs$163.99 million03/05/2024$6.68$6.75+1.05%$6.98$6.52330,706 shs$157.34 million03/04/2024$7.03$6.68-4.91%$7.06$6.47610,695 shs$155.71 millionThe Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.03/01/2024$6.65$7.03+5.64%$7.03$6.60706,257 shs$163.75 million02/29/2024$6.29$6.65+5.72%$6.97$6.221.13 million shs$155.01 million02/28/2024$9.34$6.29-32.66%$7.24$5.822.83 million shs$146.62 million02/27/2024$9.28$9.34+0.65%$9.70$9.12513,267 shs$217.72 million02/26/2024$9.19$9.28+0.98%$9.46$9.03306,790 shs$216.32 million02/23/2024$9.37$9.19-1.92%$9.38$9.06270,532 shs$214.22 million02/22/2024$9.39$9.37-0.21%$9.65$9.32264,461 shs$218.42 million02/21/2024$9.49$9.39-1.05%$9.49$9.07564,775 shs$218.86 million02/20/2024$10.03$9.49-5.38%$10.06$9.48723,383 shs$221.21 million02/19/2024$10.03$10.03$10.27$9.46589,000 shs$233.80 million02/16/2024$10.15$10.03-1.18%$10.27$9.46588,965 shs$233.78 million02/15/2024$8.51$10.15+19.27%$10.64$9.161.73 million shs$236.60 million02/14/2024$7.99$8.51+6.51%$8.55$8.00599,858 shs$198.37 million02/13/2024$8.71$7.99-8.27%$8.55$7.91780,847 shs$186.25 million02/12/2024$8.21$8.71+6.09%$9.05$8.331.51 million shs$203.03 million02/09/2024$7.57$8.21+8.45%$8.37$7.521.11 million shs$191.38 million02/08/2024$7.68$7.57-1.43%$7.98$7.36934,032 shs$176.46 million02/07/2024$7.44$7.68+3.23%$7.74$6.97993,388 shs$179.02 million02/06/2024$6.71$7.44+10.88%$7.51$6.67780,199 shs$173.41 million02/05/2024$6.66$6.71+0.75%$6.85$6.33436,891 shs$156.41 million02/02/2024$7.27$6.66-8.39%$7.19$6.65468,488 shs$155.25 million02/01/2024$7.12$7.27+2.18%$7.49$6.93757,754 shs$169.46 million01/31/2024$6.34$7.12+12.31%$7.49$6.222.03 million shs$165.85 million01/30/2024$6.00$6.34+5.58%$6.44$5.79694,439 shs$147.67 million01/29/2024$5.70$6.00+5.26%$6.02$5.67217,998 shs$139.86 million01/26/2024$5.64$5.70+1.06%$5.82$5.61315,419 shs$132.87 million Related Companies: Envoy Medical Stock Price Chart CollPlant Biotechnologies Stock Price Chart Vicarious Surgical Stock Price Chart Sanara MedTech Stock Price Chart Milestone Scientific Stock Price Chart ReWalk Robotics Stock Price Chart Renovaro Stock Price Chart ProQR Therapeutics Stock Price Chart Skye Bioscience Stock Price Chart INmune Bio Stock Price Chart Receive INGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INGN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.